Fibrinogen Alpha Chain Precursor and Apolipoprotein A-I in Urine as Biomarkers for Noninvasive Diagnosis of Calcium Oxalate Nephrolithiasis : A Proteomics Study

Abstract EN

Calcium oxalate nephrolithiasis is the most common urological disease, but noninvasive and convenient methods of diagnosis are rarely available.

Objective.

The present study aimed to identify potential urine biomarkers for noninvasive diagnosis of CaOx nephrolithiasis.

Methodology.

Urine samples from 72 patients with CaOx nephrolithiasis and 30 healthy controls were collected and proteomics analysis was performed using matrix-assisted laser desorption/ionization-time of flight-mass spectrometer (MALDI-TOF-MS).

Results.

Thirteen proteins/peptides displayed statistically significant differences.

The peptides of m/z 1207.23 and 2773.86 were selected by the genetic algorithm (GA) to build a possible diagnostic model.

The area under the curve of m/z 1207.23 and 2773.86 was 0.936 and 0.987, respectively.

The diagnostic model in distinguishing patients and healthy subjects showed 100% sensitivity and specificity.

The peak at m/z 2773.86 was identified as fibrinogen alpha chain (FGA) with the sequence G.EGDFLAEGGGVR.G, and the peak at m/z 2773.86 was identified as apolipoprotein A-I (apoA-I) with the sequence L.PVLESFKVSFLSALEEYTKKLNTQ.

Conclusion.

The study results strongly suggested that urinary FGA and apoA-I are highly sensitive and specific biomarkers for noninvasive diagnosis of CaOx nephrolithiasis.